Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy

Siegel, 2017, Cancer statistics, CA Cancer J Clin, 67, 7, 10.3322/caac.21387 Deek, 2016, Thoracic vertebral body irradiation contributes to acute hematologic toxicity during chemoradiation therapy for non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 94, 147, 10.1016/j.ijrobp.2015.09.022 Campian, 2013, Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer, Cancer Invest, 31, 183, 10.3109/07357907.2013.767342 Rose, 2011, Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy, Int J Radiat Oncol Biol Phys, 79, 800, 10.1016/j.ijrobp.2009.11.010 Yang, 2014, Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy, Radiother Oncol, 113, 29, 10.1016/j.radonc.2014.09.002 Heylmann, 2014, Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells, Biochim Biophys Acta (BBA) - Rev Cancer, 1846, 121, 10.1016/j.bbcan.2014.04.009 Sellins, 1987, Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes, J Immunol, 139, 3199, 10.4049/jimmunol.139.10.3199 Molon, 2016, T cells and cancer: how metabolism shapes immunity, Front Immunol, 7, 20, 10.3389/fimmu.2016.00020 Templeton, 2014, Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis, JNCI: J Nat Cancer Inst, 106, 10.1093/jnci/dju124 Yao, 2013, Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy, Cancer Immunol Immunother, 62, 471, 10.1007/s00262-012-1347-9 Cedrés, 2012, Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer, Clin Transl Oncol, 14, 864, 10.1007/s12094-012-0872-5 Go, 2014, Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer, Med Oncol, 31, 323, 10.1007/s12032-014-0323-y Krenn-Pilko, 2014, The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients, Br J Cancer, 110, 2524, 10.1038/bjc.2014.163 Liu, 2013, Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer, J Thoracic Dis, 5, 783 Yin, 2015, Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis, Clinics, 70, 524, 10.6061/clinics/2015(07)10 Unal, 2013, Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis?, Asian Pac J Cancer Prev., 14, 5237, 10.7314/APJCP.2013.14.9.5237 Jin, 2014, Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis, J Cancer Res Ther, 10, 160, 10.4103/0973-1482.145854 Don, 2004, Serum albumin: relationship to inflammation and nutrition, Semin Dial, 17, 432, 10.1111/j.0894-0959.2004.17603.x Koh, 2017, Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy, Medicine, 96, 10.1097/MD.0000000000006848 Lee, 2019, Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer, Sci Rep, 9, 2094, 10.1038/s41598-019-38618-3 Abravan, 2017, Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib, Clin Transl Radiat Oncol., 4, 57, 10.1016/j.ctro.2017.04.002 Lausen, 1992, Maximally selected rank statistics, Biometrics, 48, 73, 10.2307/2532740 Poulin JF. Direct Evidence for Thymic Function in Adult Humans. 1999;190(4):479-86. Liu, 2017, Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma, Radiat Oncol (London, England), 12, 90, 10.1186/s13014-017-0824-x Chadha, 2017, Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?, Int J Radiat Oncol Biol Phys, 97, 323, 10.1016/j.ijrobp.2016.10.046 Yovino, 2012, Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas, CNS Oncol, 1, 149, 10.2217/cns.12.14 Hughes, 2005, Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection, Int J Radiat Biol, 62, 1423, 10.1016/j.ijrobp.2004.12.085 Mansharamani, 2000, Peripheral blood CD4 + T-Lymphocyte counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection, Chest, 118, 712, 10.1378/chest.118.3.712 Campian, 2014, The association between severe treatment-related lymphopenia and progression free survival in patients with newly diagnosed squamous cell head and neck cancer, Head Neck, 36, 1747, 10.1002/hed.23535 Tang, 2014, Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes, Int J Radiat Biol, 89, 1084, 10.1016/j.ijrobp.2014.04.025 Schernberg, 2017, Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation, Oncotarget, 8, 11579, 10.18632/oncotarget.14584 Schernberg, 2017, Leukocytosis and neutrophilia predicts outcome in anal cancer, Radiother Oncol, 122, 137, 10.1016/j.radonc.2016.12.009 Balmanoukian, 2012, The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas, Cancer Invest, 30, 571, 10.3109/07357907.2012.700987 Jin, 2017, Higher radiation dose to immune system is correlated with poorer survival in patients with stage III non–small cell lung cancer: a secondary study of a phase 3 cooperative group trial (NRG Oncology RTOG 0617), Int J Radiat Oncol • Biol • Phys, 99, S151, 10.1016/j.ijrobp.2017.06.351 Ladbury, 2019, Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy, Int J Radiat Oncol Biol Phys, 105, 346, 10.1016/j.ijrobp.2019.05.064 Hara, 2007, Preoperative serum C-reactive protein level in non-small cell lung cancer, Anticancer Res, 27, 3001 Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? The Lancet.357(9255):539-45. Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 Kjelgaard-Hansen, 2006, Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report, Acta Vet Scand, 48, 9, 10.1186/1751-0147-48-9 Tao, 2016, The C-reactive protein/Albumin ratio is an independent prognostic factor for overall survival in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy, J Cancer, 7, 2005, 10.7150/jca.16210 Liang, 2017, Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma, Oncotarget, 8, 98135, 10.18632/oncotarget.20990